AM
UTHR icon

AGF Management’s United Therapeutics UTHR Stock Holding History

AGF Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,964
Closed -$3.21M – 760
2024
Q3 		$3.21M Buy
+8,964
New +$3.03M 0.02% 386
2024
Q2 		– Sell
-984
Closed -$226K – 760
2024
Q1 		$226K Sell
984
-10,822
-92% -$2.44M ﹤0.01% 684
2023
Q4 		$2.6M Sell
11,806
-1,585
-12% -$365K 0.02% 463
2023
Q3 		$3.02M Sell
13,391
-2,701
-17% -$622K 0.02% 355
2023
Q2 		$3.55M Buy
16,092
+2,255
+16% +$499K 0.03% 364
2023
Q1 		$3.1M Buy
+13,837
New +$3.41M 0.02% 432

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

AGF Management's UTHR Position: Q4 2024 in Review

AGF Management sold out of United Therapeutics (UTHR) in Q4 2024, closing a stake of 8,964 shares — an estimated $3.21M sold.

AGF Management first reported a position in UTHR in Q1 2023 and held it in 6 quarters. The position peaked at $3.55M in Q2 2023. 673 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

  • AGF Management reported no remaining United Therapeutics position as of Q4 2024 after selling out during the quarter.
  • AGF Management sold 8,964 United Therapeutics shares in Q4 2024, an estimated $3.21M.
  • AGF Management first reported a position in United Therapeutics in Q1 2023 and held it in 6 quarters.
  • AGF Management's United Therapeutics position peaked at $3.55M in Q2 2023.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on AGF Management's 13F filing for Q4 2024, filed 7 Feb 2025.